BAX and metabolic dysfunction-associated steatotic liver disease: Ursodeoxycholic acid activates AMPK and influences the interaction of Bcl-2/Beclin-1 and Bcl-2/Bax complexes in NAFLD rats, thereby inhibiting apoptosis [121].